ATE229519T1 - Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen - Google Patents
Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromenInfo
- Publication number
- ATE229519T1 ATE229519T1 AT97910267T AT97910267T ATE229519T1 AT E229519 T1 ATE229519 T1 AT E229519T1 AT 97910267 T AT97910267 T AT 97910267T AT 97910267 T AT97910267 T AT 97910267T AT E229519 T1 ATE229519 T1 AT E229519T1
- Authority
- AT
- Austria
- Prior art keywords
- syndromes
- prevention
- treatment
- related diseases
- estrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK119596 | 1996-10-28 | ||
| PCT/DK1997/000486 WO1998018779A1 (en) | 1996-10-28 | 1997-10-28 | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE229519T1 true ATE229519T1 (de) | 2002-12-15 |
Family
ID=8102047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97910267T ATE229519T1 (de) | 1996-10-28 | 1997-10-28 | Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0937062B1 (de) |
| JP (1) | JP2001502711A (de) |
| AT (1) | ATE229519T1 (de) |
| AU (1) | AU4772397A (de) |
| CA (1) | CA2269973A1 (de) |
| DE (1) | DE69717844T2 (de) |
| DK (1) | DK0937062T3 (de) |
| ES (1) | ES2188909T3 (de) |
| IL (1) | IL129627A0 (de) |
| NO (1) | NO992006L (de) |
| WO (1) | WO1998018779A1 (de) |
| ZA (1) | ZA979650B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2356986A1 (en) * | 1998-12-30 | 2000-07-06 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| JP4976649B2 (ja) * | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ，インク． | 化合物 |
| US7601855B2 (en) | 2004-09-21 | 2009-10-13 | Novogen Research Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| EP2635121B1 (de) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoidverbindungen und verfahren zur behandlung von krebs |
| HUE054998T2 (hu) | 2015-02-02 | 2021-10-28 | Mei Pharma Inc | Kombinációs terápiák emlõrák kezelésében való alkalmazásra |
| EP3681495A4 (de) * | 2017-09-15 | 2021-06-02 | Nyrada Pty Limited | Behandlung von exzitotoxizität |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
| DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
| HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 AT AT97910267T patent/ATE229519T1/de not_active IP Right Cessation
- 1997-10-28 AU AU47723/97A patent/AU4772397A/en not_active Abandoned
- 1997-10-28 JP JP10519945A patent/JP2001502711A/ja active Pending
- 1997-10-28 ZA ZA9709650A patent/ZA979650B/xx unknown
- 1997-10-28 CA CA002269973A patent/CA2269973A1/en not_active Abandoned
- 1997-10-28 DK DK97910267T patent/DK0937062T3/da active
- 1997-10-28 ES ES97910267T patent/ES2188909T3/es not_active Expired - Lifetime
- 1997-10-28 DE DE69717844T patent/DE69717844T2/de not_active Expired - Fee Related
- 1997-10-28 WO PCT/DK1997/000486 patent/WO1998018779A1/en active IP Right Grant
- 1997-10-28 EP EP97910267A patent/EP0937062B1/de not_active Expired - Lifetime
- 1997-10-28 IL IL12962797A patent/IL129627A0/xx unknown
-
1999
- 1999-04-27 NO NO992006A patent/NO992006L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001502711A (ja) | 2001-02-27 |
| EP0937062A1 (de) | 1999-08-25 |
| DK0937062T3 (da) | 2003-04-07 |
| AU4772397A (en) | 1998-05-22 |
| NO992006D0 (no) | 1999-04-27 |
| DE69717844D1 (de) | 2003-01-23 |
| EP0937062B1 (de) | 2002-12-11 |
| DE69717844T2 (de) | 2003-10-02 |
| ES2188909T3 (es) | 2003-07-01 |
| WO1998018779A1 (en) | 1998-05-07 |
| NO992006L (no) | 1999-06-25 |
| ZA979650B (en) | 1998-04-28 |
| CA2269973A1 (en) | 1998-05-07 |
| IL129627A0 (en) | 2000-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RO115522B1 (ro) | Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament | |
| NO20006645L (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
| MX9702865A (es) | Agentes estrogenicos. | |
| ATE237633T1 (de) | Analogen des keratinozytenwachstumfaktors | |
| DK0807633T3 (da) | Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner | |
| ATE229518T1 (de) | Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
| UA35607C2 (uk) | Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання | |
| ATE229519T1 (de) | Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen | |
| ATE231141T1 (de) | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| NO992010L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| RU94000064A (ru) | Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции | |
| NO992008L (no) | Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992005L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992002L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992004L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| DE69428127D1 (de) | Schädlingsbekämpfungsmittel | |
| RU93055683A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование, композиция | |
| RU93055680A (ru) | Ингибиторы вич-протеазы, способ получения, их использование, композиция | |
| RU94035756A (ru) | Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0937062 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |